dc.contributor.author | Koyuncu, Mehmet | |
dc.contributor.author | Atmaca, Sinan | |
dc.contributor.author | Coban, Ahmet Yilmaz | |
dc.contributor.author | Basar, Figen | |
dc.contributor.author | Civici, Senguel | |
dc.date.accessioned | 2020-06-21T15:18:05Z | |
dc.date.available | 2020-06-21T15:18:05Z | |
dc.date.issued | 2008 | |
dc.identifier.issn | 1305-5267 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12712/19578 | |
dc.description | WOS: 000259303100004 | en_US |
dc.description.abstract | OBJECTIVE: The aim of this study was to investigate the relationship between Endothelin-1 (ET-1) and hearing levels in patients with sudden sensorineural hearing loss (SSHL). STUDY DESIGN: Prospective. SETTING: Tertiary referral center. PATIENTS AND METHODS: Thirty-seven patients with SSHL were included in the study. Patients who recieved treatment before admission or had symptoms for more than 3 days were not enrolled. Endothelin levels of 37 patients diagnosed as having SSHL were investigated admission and 3rd month follow-up with reference to the hearing recovery. RESULTS: Fifteen patients, with complete recovery after treatment, had statistically lower enclothelin-1 levels at 3rd month follow-up compared to the level at admission (p<0.001). CONCLUSION: We suggest vascular reasons may play an important role in SSHL and the treatment should be planned accordingly. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Mediterranean Soc Otology & Audiology | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.title | Plasma endothelin-1 levels in patients with sudden sensorineural hearing loss | en_US |
dc.type | article | en_US |
dc.contributor.department | OMÜ | en_US |
dc.identifier.volume | 4 | en_US |
dc.identifier.issue | 2 | en_US |
dc.identifier.startpage | 86 | en_US |
dc.identifier.endpage | 91 | en_US |
dc.relation.journal | Mediterranean Journal of Otology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |